Search clinical trials for: UGN-201

Total 4297 results

Gate Neurosciences, Inc

Completed

AGN-241751 in the Treatment of Major Depressive Disorder

Major Depressive Disorder

United States
Allergan

Completed

A Study to Assess Adverse Events and Change in Disease Activity of Intramuscular AGN-151586 Injection in Adult Participants With Glabellar Lines

Glabellar Lines

United States, Canada, Germany, Hungary, Poland
Vitae Pharmaceuticals, Inc.

Terminated

AGN-242428 in the Treatment of Plaque Psoriasis

Plaque Psoriasis

United States
Allergan

Terminated

Safety and Efficacy of AGN 203818 for Pain Associated With Fibromyalgia Syndrome

Fibromyalgia

Switzerland, United States, United Kingdom
pH Pharma

Completed

PK/PD, Safety and Tolerability of PHP-201 Topical Eye Drop in Korean and Japanese Healthy Subjects

Healthy Volunteer

Korea, Republic of
Kaiser Clinic and Hospital

Completed

Preoperative and Postoperative Endoscopic Alterations in Patients Submitted to Gastric Bypass Without a Ring

Obesity

Brazil
Allergan

Completed

Safety and Efficacy of AGN 203818 in Patients With Painful Diabetic Peripheral Neuropathy

Diabetic Neuropathy, Painful

United States
AstraZeneca

Completed

Safety and Tolerability Study of MEDI0382 in Japanese Preobese or Obese Subjects With Type 2 Diabetes

Type 2 Diabetes

Japan
Suzhou Connect Biopharmaceuticals, Ltd.

Completed

A Study to Evaluate the Pharmacokinetics Similarity of CBP-201 in Healthy Adult Chinese Subjects

Healthy Adult Subjects

China
Crucell Holland BV

Completed

Re-licensing Study to Assess Inflexal V Formulated With WHO Recommended Influenza Strains

Influenza

Switzerland
Ohio State University

Recruiting

Follow-up Gun Study: Can Safety Videos Mitigate Interest in Guns in Children?

Psychology, Social | Adolescent Behavior

United States
Allergan

Completed

Safety and Pharmacokinetics of Abicipar Pegol Intravitreal Injections in Patients With Neovascular AMD

Macular Degeneration

United States
Herbert Lyerly

Withdrawn

HS-201, an HSP90 Inhibitor-linked Verteporfin for Detection of Solid Malignancies

Solid Tumor

United States
Tenaya Therapeutics

Recruiting

Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MYBPC3 Mutation-associated HCM (MyPEAK-1)

Hypertrophic Cardiomyopathy

United States
COUR Pharmaceutical Development Company, Inc.

Terminated

CNP-201 in Subjects With Peanut Allergy

Peanut Allergy

United States
COUR Pharmaceutical Development Company, Inc.

Terminated

Evaluate the Safety, Tolerability, Pharmacodynamics, and Efficacy of CNP-201 in Subjects Ages 16-35 With Peanut Allergy

Peanut Allergy

United States
Zafgen, Inc.

Completed

An Efficacy, Safety and Pharmacokinetics Study of Beloranib (ZGN-440 for Injectable Suspension) in Obese Subjects

Obesity

Australia
McMaster University
Canadian Institutes of Health Research (CIHR)

Recruiting

Relative Impacts on Preventative Primary Care--a Longitudinal Evaluation of COVID-19:Phase 1 (RIPPLE-C)

Diabetes Mellitus | Chronic Kidney Diseases | Chronic Obstructive Pulmonary Disease | Osteoarthritis | Dementia | Congestive Heart Failure | Depression, Anxiety

Canada
University Health Network, Toronto
Bayer; Prostate Cancer Canada

Not yet recruiting

Study of Radiation Therapy in Combination With Darolutamide + Degarelix in Intermediate Risk Prostate Cancer (SChLAP/IDC)

Prostate Cancer

Canada
Terns, Inc.

Completed

AVIATION Study: A Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy Study of TERN-201 in Patients With Non-Cirrhotic Non-Alcoholic Steatohepatitis

NASH - Nonalcoholic Steatohepatitis

United States
Introgen Therapeutics

Completed

Study to Determine the Efficacy and Safety of Docetaxel and Doxorubicin With INGN 201 in Locally Advanced Breast Cancer

Locally Advanced Breast Cancer (LABC)

United States
University of Chicago

Recruiting

TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers

Head and Neck Cancer | HPV Positive Oropharyngeal Squamous Cell Carcinoma | HPV | Human Papilloma Virus

United States
Precision Biologics, Inc

Recruiting

Study of NEO-201 in Solid Tumors Expansion Cohorts

Cervical Cancer | Non Small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Uterine Cancer

United States
AbbVie

Enrolling by invitation

Long-term Extension Study to Assess Adverse Events of Oral Atogepant Tablets in Pediatric Participants (6 to 17 Years of Age) With Episodic Migraine

Episodic Migraine

United States, Canada, Denmark, Hungary, Italy, Poland, Puerto Rico, Spain, United Kingdom, Israel, Japan, Sweden
Chinese University of Hong Kong

Completed

Focal Thermal Therapy Acupoint OA Knee RCT (ThermAcuRCT)

Osteoarthritis, Knee | Randomized Controlled Trial
Charles University, Czech Republic

Completed

Percussive Therapy Reduced EMG Activity During Calf Raise in Limbs With and Without Chronic Ankle Instability

Ankle Injuries

Czechia
Riphah International University

Completed

Comparative Effects of Gun Massager and Transverse Friction Massage in Patients With Plantar Fasciitis

Plantar Fascitis

Pakistan
Massachusetts General Hospital

Recruiting

The Impact of Ibutamoren on Nonalcoholic Fatty Liver Disease

NAFLD | NASH - Nonalcoholic Steatohepatitis | Nonalcoholic Fatty Liver

United States
Translational Research in Oncology
Bayer

Completed

A Study to Evaluate Changes in Human Breast Cancer Tissue Following Short-Term Use of Darolutamide

Breast Cancer Female

Germany, Canada, United States
Bellicum Pharmaceuticals

Completed

Safety Study of BPX-201 Dendritic Cell Vaccine Plus AP1903 in Metastatic Castrate Resistent Prostate Cancer

Castrate Resistent Prostate Cancer

United States
Minovia Therapeutics Ltd.

Recruiting

Evaluate the Safety and Therapeutic Effects of Transplantation of MNV-201 in Pediatric Patients With Pearson Syndrome

Mitochondrial Diseases | Pearson Syndrome

Israel
University Health Network, Toronto

Completed

High Dose vs. Standard Influenza Vaccine in Adult SOT

Influenza | Immunosuppression

Canada
AIM ImmunoTech Inc.

Terminated

Safety Study of FluMist With and Without Ampligen

Influenza, Human

United States
Sanofi Pasteur, a Sanofi Company

Completed

Study of Recombinant Influenza Vaccine Containing Different H3 Antigens Without or With Adjuvant in Healthy Adult Subjects (FBP00004)

Healthy Volunteers | Influenza Immunisation

United States
Allergan

Completed

Safety and Efficacy of AGN 210669 Ophthalmic Solution in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma

Ocular Hypertension | Glaucoma

United States
Faculty of Medical Sciences, Clinical Hospital

Completed

Effects of Yogurt With Probiotics in Adults With Type 2 Diabetes Mellitus

Type2 Diabetes

Spain
Assistance Publique - Hôpitaux de Paris

Completed

Efficacy and Safety of Influenza Vaccine During Sarcoidosis (SARCOVAC)

Influenza Vaccine | Sarcoidosis

France
Rapa Therapeutics LLC

Recruiting

RAPA-201 Therapy of Solid Tumors

Breast Cancer | Head and Neck Cancer | Gastric Cancer | Solid Tumor | Bladder Cancer | Triple Negative Breast Cancer | Esophageal Adenocarcinoma | Esophageal Squamous Cell Carcinoma | Malignant Melanoma | Carcinoma of Unknown Primary | Squamous Cell Carcinoma of Larynx | Squamous Cell Carcinoma of Oral Cavity | Squamous Cell Carcinoma of Nasopharynx and other conditions

United States
Cabaletta Bio

Not yet recruiting

RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis

Generalized Myasthenia Gravis (gMG)
Blue Lake Biotechnology Inc.

Completed

Phase 1 Study of BLB-201 Vaccine in Healthy Young and Older Adults

Respiratory Syncytial Virus Infections

United States
Jonathan H. Waters
HbO2 Therapeutics LLC

Available

Expanded Access IND Administration of HBOC-201 in Patients With Severe Acute Anemia

Anemia Severe

United States
Michael Gunn
National Cancer Institute (NCI)

Withdrawn

Monocyte Antigen Carrier Cells for Newly Diagnosed GBM (DEMAND)

Glioblastoma | Glioma, Malignant

United States
Oxford BioMedica

Completed

Phase I Dose Escalation Safety Study of RetinoStat in Advanced Age-Related Macular Degeneration (AMD) (GEM)

Age Related Macular Degeneration

United States
National Cancer Institute (NCI)

Completed

Gene Therapy in Preventing Cancer in Patients With Premalignant Carcinoma of the Oral Cavity or Pharynx

Lip and Oral Cavity Cancer | Oropharyngeal Cancer | Tongue Cancer | Stage 0 Lip and Oral Cavity Cancer | Stage 0 Oropharyngeal Cancer

United States
Blue Lake Biotechnology Inc.

Recruiting

A Study of BLB-201 RSV Vaccine in Infants and Children

Respiratory Syncytial Virus Infections

United States
Allergan

Completed

Efficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral Atogepant (AGN-241689) in Episodic Migraine Prevention

Migraine, With or Without Aura

United States
Seagen Inc.

Terminated

A Safety Study of SGN-CD123A in Patients With Acute Myeloid Leukemia

Acute Myeloid Leukemia

United States
Seagen Inc.

Completed

A Safety Study of SGN-CD19A for Leukemia and Lymphoma

Burkitt Lymphoma | Precursor B-cell Lymphoblastic Leukemia-Lymphoma

United States
Seagen Inc.

Completed

A Phase 1 Dose-escalation Trial of SGN-75 in CD70-positive Non-Hodgkin Lymphoma or Renal Cell Carcinoma

Lymphoma, Non-Hodgkin | Carcinoma, Renal Cell

United States
Cabaletta Bio

Not yet recruiting

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

Systemic Sclerosis | Scleroderma

United States

Search clinical trials for: UGN-201

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Taiwan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations